beta-D-GlcA3S-(1->3)-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)]2-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer

Term ID

CHEBI:60745

Synonyms

(2S,3R,4E)-2-alkanamido-3-hydroxyoctadec-4-en-1-yl 3-O-sulfo-beta-D-glucopyranuronosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-b
3-O-SO3-beta-D-GlcA-(1->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer
3-O-SO3-beta-D-GlcpA-(1->3)-[beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)]2-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer
3-O-SO3-beta-D-GlcpA-(1->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer
HexLK1
HNK-1 glycolipid
IV3SO4GlcA-nLc6-Cer
SGGL-2
SGLPG
sulfate-3-glucuronyl-lactosaminyl paragloboside
sulfate-3-glucuronyl-lactosaminyl-paragloboside
sulfated 3-glucuronyl-lactosaminyl paragloboside
sulfated 3-glucuronyl-lactosaminyl-paragloboside
sulfoglucuronyl-lactosaminyl paragloboside
sulfoglucuronyl-lactosaminyl-paragloboside

Definition

A glycoheptaosylceramide having beta-D-GlcA3S-(1->3)-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)]2-beta-D-Gal-(1->4)-beta-D-Glc as the heptasaccharide component.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: glycoheptaosylceramide

glycoheptaosylceramide Show first 5 Terms
inverse is_conjugate_base_of: 3-O-sulfo-beta-D-glucuronosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(2-)

3-O-sulfo-beta-D-glucuronosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(2-) Show first 5 Terms
is_conjugate_acid_of: 3-O-sulfo-beta-D-glucuronosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(2-)

3-O-sulfo-beta-D-glucuronosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(2-) Show first 5 Terms

Phenotype

Phenotype resulting from beta-D-GlcA3S-(1->3)-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)]2-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer

Phenotype where environments contain beta-D-GlcA3S-(1->3)-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)]2-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer

Phenotype modified by environments containing beta-D-GlcA3S-(1->3)-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)]2-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer

Human Disease Model